To confirm that HuR impacts GLS isoforms, both at the protein and mRNA levels, we knocked down ELAVL1 in 6 breast cancer cell lines (SKBR3, BT549, MDA-MB-231, MDA-MB-157, HCC38, and Hs578t). This evidence concerns the gene ELAVL1 and breast carcinoma.